New injection offers hope for teens battling severe eczema
NCT ID NCT06495229
Summary
This study is testing an investigational injection called CM310 in 180 teenagers with moderate-to-severe eczema (atopic dermatitis). The main goal is to see how safe the treatment is and if it helps improve skin symptoms and reduce itching. All participants in this open-label study will receive the treatment, and researchers will track changes in their skin condition and quality of life over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.